Susceptibility profiles of bacteria causing urinary tract infections in Southern Tunisia.

[1]  G. Málaga,et al.  Worrisome high frequency of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case-control study. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[2]  S. El Mhamdi,et al.  Hospitalizations for communicable diseases in a developing country: prevalence and trends-Monastir, Tunisia, 2002-2013. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[3]  F. Chang,et al.  Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[4]  M. Aouni,et al.  Dissemination of multidrug-resistant blaCTX-M-15/IncFIIk plasmids in Klebsiella pneumoniae isolates from hospital- and community-acquired human infections in Tunisia. , 2015, Diagnostic microbiology and infectious disease.

[5]  Salma Smaoui,et al.  Résistance aux antibiotiques des entérobactéries responsables d’infections urinaires communautaires à Sfax (Tunisie) , 2015 .

[6]  J. Boukadida,et al.  [Profile and susceptibility to antibiotics in urinary tract infections in children and newborns from 2012 to 2013: Data from 1879 urine cultures]. , 2015, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[7]  L. Arsalane,et al.  Antimicrobial susceptibility of urinary Klebsiella pneumoniae and the emergence of carbapenem-resistant strains: A retrospective study from a university hospital in Morocco, North Africa , 2015 .

[8]  Yoshimasa Yamamoto,et al.  Wide dissemination of extended-spectrum β-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula , 2015, Infection and drug resistance.

[9]  S. Kammoun,et al.  [Antibiotic resistance of community-acquired uropathogenic Enterobacteriaceae isolated in Sfax (Tunisia)]. , 2015, Medecine et maladies infectieuses.

[10]  M. Kamal,et al.  Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. , 2015, Saudi journal of biological sciences.

[11]  A. Ferjani,et al.  [Profile and susceptibility to antibiotics in urinary tract infections in children and newborns from 2012 to 2013: Data from 1879 urine cultures]. , 2015, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[12]  K. Akashi,et al.  Community spread of extended-spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in Japan. , 2013, Journal of medical microbiology.

[13]  B. Mégarbane,et al.  [Enterobacteriaceae producing extended spectrum beta-lactamase: epidemiology, risk factors, and prevention]. , 2013, La Revue de medecine interne.

[14]  D. Vodovar,et al.  Entérobactéries productrices de bêta-lactamases à spectre élargi : épidémiologie, facteurs de risque et mesures de prévention , 2013 .

[15]  A. Pathak,et al.  High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India , 2012, Infection and drug resistance.

[16]  A. Ben Haj Khalifa,et al.  [Epidemiological study of Klebsiella spp. uropathogenic strains producing extended-spectrum β-lactamase in a Tunisian university hospital, 2009]. , 2012, Pathologie-biologie.

[17]  Pascal Hallouët.  86 – Examen cytobactériologique des urines (ECBU) , 2010 .

[18]  A. Marchese,et al.  The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. , 2009, International journal of antimicrobial agents.

[19]  Y. Sekhsokh,et al.  [Frequency and antibiotic susceptibility of bacteria identified in urine]. , 2008, Medecine et maladies infectieuses.

[20]  S. Hamzaoui,et al.  Frquence et sensibilit aux antibiotiques des bactries isoles dans les urines , 2008 .

[21]  K. Laupland,et al.  Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern , 2008 .

[22]  V. Dubois,et al.  Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Community and Private Health Care Centers , 2003, Antimicrobial Agents and Chemotherapy.

[23]  V. Dubois,et al.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. , 2003, Antimicrobial agents and chemotherapy.

[24]  B. Kristiansen,et al.  Urinary tract infections in Norway: bacterial etiology and susceptibility. A retrospective study of clinical isolates. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.